Key points from article :
Genetic test-kit companies share collected genetic data with drug development companies.
23andMe Inc. shared its genetic data of over 8 million people with GSK to make profits.
80% of customers have consented to their genetic information being used for research purposes.
Some argue that it isn’t ethical to profit from the genetic data of paying customers.
Drugs based on genetic information are two times more likely to succeed in clinical trials.
